American College of Rheumatology

185 articles about American College of Rheumatology

• HSS Rheumatologists, Social Worker Honored by American College of Rheumatology

  11/12/2022

  The American College of Rheumatology and the Association of Rheumatology Professionals have honored two rheumatologists and a social worker at Hospital for Special Surgery with prestigious awards.

• 

  Positive Data in Psoriatic Arthritis, Lupus Presented at EULAR

  6/3/2022

  Acelyrin, Affibody AB and Inmagene Biopharmaceuticals presented positive Phase II data for izokibep in psoriatic arthritis, while Aurinia's Lupkynis hit post-hoc treatment targets in lupus nephritis.

• HSS Study Sheds Light on Real-World Treatment Patterns of Psoriatic Arthritis

  11/9/2021

  Despite clear directives outlined in the updated guidelines published by the American College of Rheumatology/National Psoriasis Foundation in 2018, there is limited data regarding medication use in real-world clinical practice and patient medication preferences for the treatment of psoriatic arthritis.

• SAPHNELO Consistently Reduces Systemic Lupus Erythematosus Disease Activity Regardless of Disease Duration and Prior Treatment

  11/1/2021

  New subgroup analyses from the TULIP Phase III clinical trial program showed SAPHNELO, a first-in-class type I interferon antagonist, in addition to standard therapy, resulted in a greater reduction in systemic lupus erythematosus disease activity regardless of disease duration, standard therapy type and prior treatment, compared to standard therapy alone.

• New ACR White Paper Highlights Health Care Challenges Affecting the Rheumatic Disease Community

  5/12/2021

  The American College of Rheumatology announced the launch of a new white paper, “Rheumatic Diseases in America: Confronting the Challenge,” which provides an overview of the current health care challenges facing the rheumatic disease community and highlights the importance of receiving timely and appropriate treatment from a rheumatology health professional.

• American College of Rheumatology COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

  2/11/2021

  The American College of Rheumatology has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases.

• Celltrion Healthcare Presents Positive Top-Line Efficacy and Safety Results for CT-P17 in the Treatment of Rheumatoid Arthritis

  11/2/2020

  New data to be presented at the American College of Rheumatology Convergence 2020 demonstrate that the efficacy, pharmacokinetics and overall safety of CT-P17, a proposed high concentration and citrate-free adalimumab biosimilar, is comparable to reference adalimumab in the treatment of rheumatoid arthritis patients.

• Rheumatology Leaders and Patient Advocates Urge Congress to Address Care Challenges Exacerbated by COVID-19 During the Virtual “Advocates for Arthritis” Event

  9/14/2020

  The American College of Rheumatology (ACR) will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.

• “My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During September’s Rheumatic Disease Awareness Month

  9/2/2020

  In a new survey of Americans living with rheumatic disease, 68% report their disease sometimes feels invisible because they don’t “look sick”

• During Virtual Hill Visits, Rheumatology Leaders Urge Lawmakers to Provide More Targeted COVID-19 Relief for Healthcare Practices

  5/21/2020

  In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology (ACR) are sounding the alarm about the economic impact of COVID-19 on rheumatology practices and the urgent need for more targeted relief that will help specialty practices remain solvent and continue to serve patients.

• ACR Releases Gout Management Guideline with Emphasis on Treat-to-Target Strategy for Urate Lowering Therapy

  5/11/2020

  ACR Releases Gout Management Guideline with Emphasis on Treat-to-Target Strategy for Urate Lowering Therapy

• American College of Rheumatology Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases

  2/24/2020

  The American College of Rheumatology published the 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

• New Osteoarthritis (OA) Treatment Guidelines Issued…Expert Medical Organization Conditionally Recommends the Use of Topical Capsaicin for Pain due to OA of the Knee

  1/22/2020

  Vizuri Health Sciences LLC reports that the American College of Rheumatology, an organization of physicians and health professionals that advances education, research, advocacy and practice support for the care of people with arthritis, has announced updated 2019 treatment guidelines for the management of OA of the hand, hip, and knee.

• American College of Rheumatology/Arthritis Foundation Release Updated Treatment Guideline for Osteoarthritis

  1/7/2020

  The American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee.

•  Kezar Announces Promising New Data with KZR-616 at the American College of Rheumatology Annual Meeting

  11/12/2019

  Majority of patients completing 13 weeks of treatment demonstrated significant improvement on at least 2 measures of disease activity

• Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis

  6/14/2019

  Data are part of the DISCOVER 1 and 2 program, the first Phase 3 studies to evaluate a selective IL-23 p19 inhibitor in the treatment of psoriatic arthritis

• 2019 ACR/ARP Annual Meeting Press Registration Opens

  6/10/2019

  The American College of Rheumatology and the Association for Rheumatology Professionals welcomes members of the press to write about research presented at the 2019 ACR/ARP Annual Meeting.

• American College of Rheumatology Statement on CMS Medicare Advantage Final Rule

  5/17/2019

  In August 2018, the CMS announced that Medicare Advantage plans would be allowed to utilize step therapy for Part B drugs.

• The ACR and the Arthritis Foundation Present New Guidelines Offering Therapeutic Approaches and Treatment Options for Juvenile Idiopathic Arthritis

  4/29/2019

  The American College of Rheumatology, in partnership with the Arthritis Foundation, released two guidelines on juvenile idiopathic arthritis.

• American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements

  4/1/2019

  The American College of Rheumatology has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.